El paciente con diabetes y COVID-19

Referencias bibliográficas

• Abdi A, Jalilian M, Sarbarzeh PA, Vlaisavljevic Z. Diabetes and COVID-19: A systematic review on the current evidences. Diabetes Res Clin Pract. 2020;166:108347. doi:10.1016/j.diabres.2020.108347
• Adhikari SP, Meng S, Wu Y-J, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):29. doi:10.1186/s40249-020-00646-x
• Agencia española de medicamentos y productos Sanitarios. Tratamientos disponibles sujetos a condiciones especiales de acceso para el manejo de la infección respiratoria por SARS-CoV-2. 2020. https://www.aemps.gob.es/la-aemps/ultima-informacion-de-la-aemps-acerca-del-covid-19/tratamientos-disponibles-para-el-manejo-de-la-infeccion-respiratoria-por-sars-cov-2/. Accessed August 29, 2020.
• Aiken LH, Sloane DM, Bruyneel L, et al. Nurse staffing and education and hospital mortality in nine European countries: a retrospective observational study. Lancet. 2014;383(9931):1824-1830. doi:10.1016/S0140-6736(13)62631-8
• Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8(9):782-792. doi:10.1016/S2213-8587(20)30238-2
• Ball JE, Murrells T, Rafferty AM, Morrow E, Griffiths P. ‘Care left undone’ during nursing shifts: associations with workload and perceived quality of care. BMJ Qual Saf. 2014;23(2):116-125. doi:10.1136/bmjqs-2012-001767
• Barber TM. COVID-19 and diabetes mellitus: implications for prognosis and clinical management. Expert Rev Endocrinol Metab. 2020;15(4):227-236. doi:10.1080/17446651.2020.1774360
• Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. August 2020. doi:10.1016/S2213-8587(20)30272-2
• Batawi S, Tarazan N, Al-Raddadi R, et al. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS). Health Qual Life Outcomes. 2019;17(1):101. doi:10.1186/s12955-019-1165-2
• BMJ. Coronavirus Disease 2019 (COVID-19). Aug 10. BMJ Best Practise; 2020.
• Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(6):546-550. doi:10.1016/S2213-8587(20)30152-2
• Burke RM, Midgley CM, Dratch A, et al. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 — United States, January–February 2020. MMWR Morb Mortal Wkly Rep. 2020;69(9):245-246. doi:10.15585/mmwr.mm6909e1
• Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603. doi:10.1001/jama.2020.12603
• Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J, et al. Características clínicas de los pacientes hospitalizados con COVID-19 en España: resultados del Registro SEMI-COVID-19. Rev Clínica Española. July 2020. doi:10.1016/j.rce.2020.07.003
• Ceccarelli M, Berretta M, Rullo EV, Nunnari G, Cacopardo B. Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Eur Rev Med Pharmacol Sci. 2020;24(5):2781-2783. doi:10.26355/eurrev_202003_20551
• Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). 2020. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/index.html. Accessed August 29, 2020.
• Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523. doi:10.1016/S0140-6736(20)30154-9
• Chaudhry R, Dranitsaris G, Mubashir T, Bartoszko J, Riazi S. A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes. EClinicalMedicine. 2020;25:100464. doi:10.1016/j.eclinm.2020.100464
• Chen Y, Yang D, Cheng B, et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care. 2020;43(7):1399-1407. doi:10.2337/dc20-0660
• Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973-1987. doi:10.1016/S0140-6736(20)31142-9
• Clark A, Jit M, Warren-Gash C, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Heal. 2020;8(8):e1003-e1017. doi:10.1016/S2214-109X(20)30264-3
• Corum J, Grady D, Wee S-L, Zimmer C. Coronavirus Vaccine Tracker. The New York Times. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html. Published 2020. Accessed August 28, 2020.
• COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines (Last Updated: August 27, 2020). National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/. Accessed August 29, 2020.
• Cristelo C, Azevedo C, Marques JM, Nunes R, Sarmento B. SARS-CoV-2 and diabetes: New challenges for the disease. Diabetes Res Clin Pract. 2020;164:108228. doi:10.1016/j.diabres.2020.108228
• Cyranoski D. Mystery deepens over animal source of coronavirus. Nature. 2020;579(7797):18-19. doi:10.1038/d41586-020-00548-w
• de Andrés-Gimeno B, Solís-Muñoz M, Revuelta-Zamorano M, et al. Cuidados enfermeros en el paciente adulto ingresado en unidades de hospitalización por COVID-19. Enfermería Clínica. May 2020. doi:10.1016/j.enfcli.2020.05.016
• Doremalen N van, Lambe T, Spencer A, et al. ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques (preprint). 2020. doi:10.1101/2020.05.13.093195
• European Centre for Disease Prevention and Control: an agency of the European Union. COVID-19 situation update worldwide, as of 15 August 2020. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases. Published 2020. Accessed August 15, 2020.
• Folegatti PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467-478. doi:10.1016/S0140-6736(20)31604-4
• Forni D, Cagliani R, Clerici M, Sironi M. Molecular Evolution of Human Coronavirus Genomes. Trends Microbiol. 2017;25(1):35-48. doi:10.1016/j.tim.2016.09.001
• Gold JAW, Wong KK, Szablewski CM, et al. Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 — Georgia, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69(18):545-550. doi:10.15585/mmwr.mm6918e1
• Hartmann-Boyce J, Morris E, Goyder C, et al. Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters. Diabetes Care. 2020;43(8):1695-1703. doi:10.2337/dc20-1192
• He J, Guo Y, Mao R, Zhang J. Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis. J Med Virol. August 2020:jmv.26326. doi:10.1002/jmv.26326
• Hinkle JL, Cheever KH. Valoración y tratamiento del paciente con diabetes. In: Brunner y Suddarth Enfermería Medicoquirúrgica. 14a ed. Barcelona, España: Wolters Kluwer; 2019.
• Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. August 2020. doi:10.1016/S2213-8587(20)30271-0
• Hu Z, Song C, Xu C, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020;63(5):706-711. doi:10.1007/s11427-020-1661-4
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
• Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):395-403. doi:10.1016/j.dsx.2020.04.018
• Iacobellis G, Penaherrera CA, Bermudez LE, Bernal Mizrachi E. Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes. Diabetes Res Clin Pract. 2020;164:108185. doi:10.1016/j.diabres.2020.108185
• International Diabetes Federation. COVID-19 and diabetes. https://www.idf.org/aboutdiabetes/what-is-diabetes/covid-19-and-diabetes/1-covid-19-and-diabetes.html. Published 2020. Accessed August 27, 2020.
• International Diabetes Federation. IDF Diabetes Atlas. 9th edn. Brussels, Belgium https://www.diabetesatlas.org/.
• International Diabetes Federation. Information on Coronavirus Disease 2019 (COVID-19) Outbreak and Guidance for People with Diabetes. Brussels, Belgium; 2020. https://www.idf.org/images/IDF_Europe/Information_on_Corona-Virus_Disease_2019__COVID-19_outbreak_and_guidance_for_people_with_diabetes_-_Final.pdf.
• Jalava K. First respiratory transmitted food borne outbreak? Int J Hyg Environ Health. 2020;226:113490. doi:10.1016/j.ijheh.2020.113490
• Jiang L, Tang K, Levin M, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. August 2020. doi:10.1016/S1473-3099(20)30651-4
• Jin J-M, Bai P, He W, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Heal. 2020;8. doi:10.3389/fpubh.2020.00152
• Kasraeian M, Zare M, Vafaei H, et al. COVID-19 pneumonia and pregnancy; a systematic review and meta-analysis. J Matern Neonatal Med. May 2020:1-8. doi:10.1080/14767058.2020.1763952
• Katulanda P, Dissanayake HA, Ranathunga I, et al. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Diabetologia. 2020;63(8):1440-1452. doi:10.1007/s00125-020-05164-x
• Killerby ME, Link-Gelles R, Haight SC, et al. Characteristics Associated with Hospitalization Among Patients with COVID-19 — Metropolitan Atlanta, Georgia, March–April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(25):790-794. doi:10.15585/mmwr.mm6925e1
• Koliaki C, Tentolouris A, Eleftheriadou I, Melidonis A, Dimitriadis G, Tentolouris N. Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns. J Clin Med. 2020;9(7):2288. doi:10.3390/jcm9072288
• Kumar A, Arora A, Sharma P, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):535-545. doi:10.1016/j.dsx.2020.04.044
• Lam TT-Y, Jia N, Zhang Y-W, et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. 2020;583(7815):282-285. doi:10.1038/s41586-020-2169-0
• Li C, Ji F, Wang L, et al. Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China. Emerg Infect Dis. 2020;26(7):1626-1628. doi:10.3201/eid2607.200718
• Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med. 2020;382(13):1199-1207. doi:10.1056/NEJMoa2001316
• Linda J. Saif. Animal Coronaviruses: Lessons for SARS. In: Knobler S, Mahmoud A, Lemon S, Mack A, Sivitz L, Oberholtzer K, eds. Learning from SARS: Preparing for the Next Disease Outbreak. Washington, DC, USA: THE NATIONAL ACADEMIES PRESS; 2004:138-147. https://www.ncbi.nlm.nih.gov/books/NBK92462/pdf/Bookshelf_NBK92462.pdf.
• Lippi A, Domingues R, Setz C, Outeiro TF, Krisko A. SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration. Mov Disord. 2020;35(5):716-720. doi:10.1002/mds.28084
• Liu J, Liao X, Qian S, et al. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. 2020;26(6). doi:10.3201/eid2606.200239
• Lu L, Zhong W, Bian Z, et al. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis. J Infect. July 2020. doi:10.1016/j.jinf.2020.07.002
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-574. doi:10.1016/S0140-6736(20)30251-8
• Lu S, Lin J, Zhang Z, et al. Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients. J Med Virol. March 2020. doi:10.1002/jmv.25776
• Luo S-H, Liu W, Liu Z-J, et al. A confirmed asymptomatic carrier of 2019 novel coronavirus. Chin Med J (Engl). 2020;133(9):1123-1125. doi:10.1097/CM9.0000000000000798
• Masters P S & Perlman S. Fields Virology Vol. 2. (Knipe, D. M. & Howley PM, ed.). Lippincott Williams & Wilkins; 2013.
• Millett GA, Jones AT, Benkeser D, et al. Assessing differential impacts of COVID-19 on black communities. Ann Epidemiol. 2020;47:37-44. doi:10.1016/j.annepidem.2020.05.003
• Ministerio de Asuntos Económicos y Transferencia y Digital. Asistencia COVID-19. https://play.google.com/store/apps/details?id=es.gob.asistenciacovid19&hl=es_419. Published 2020. Accessed August 30, 2020.
• Ministerio de Asuntos Económicos y Transferencia y Digital. Radar COVID. https://play.google.com/store/apps/details?id=es.gob.radarcovid&hl=es_419. Published 2020. Accessed August 30, 2020.
• Ministerio de Sanidad de España. Anexo I: Diabetes mellitus tipo 1 y tipo 2. In: Guía de Actuación Para Personas Con Condiciones de Salud Crónicas y Personas Mayores En Situación de Confinamiento. Estado de Alarma Por COVID-19. ; 2020. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/CRONICOS20200403.pdf.
• Ministerio de Sanidad de España: Centro de Coordinación de Alertas y Emergencias Sanitarias. Información científico-técnica, enfermedad por coronavirus, COVID-19. 07-03. https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/ITCoronavirus.pdf. Published 2020. Accessed August 17, 2020.
• Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment. N Engl J Med. 2020;382(8):692-694. doi:10.1056/NEJMp2000929
• Ngai JC, Ko FW, Ng SS, To K-W, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3):543-550. doi:10.1111/j.1440-1843.2010.01720.x
• Ong SWX, Tan YK, Chia PY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. 2020;323(16):1610. doi:10.1001/jama.2020.3227
• Oran DP, Topol EJ. Prevalence of Asymptomatic SARS-CoV-2 Infection. Ann Intern Med. June 2020:M20-3012. doi:10.7326/M20-3012
• Pal R, Bhadada SK. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):513-517. doi:10.1016/j.dsx.2020.04.049
• Peiris JSM. Coronaviruses. In: Clinical Virology. 4th end. Washington, DC, USA: ASM Press; 2016. doi:10.1128/9781555819439
• Phan LT, Nguyen T V, Luong QC, et al. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. N Engl J Med. 2020;382(9):872-874. doi:10.1056/NEJMc2001272
• Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and Mortality among Black Patients and White Patients with Covid-19. N Engl J Med. 2020;382(26):2534-2543. doi:10.1056/NEJMsa2011686
• Recio-Saucedo A, Dall’Ora C, Maruotti A, et al. What impact does nursing care left undone have on patient outcomes? Review of the literature. J Clin Nurs. 2018;27(11-12):2248-2259. doi:10.1111/jocn.14058
• Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Coronavirus Pandemic (COVID-19). Our World Data. 2020. https://ourworldindata.org/coronavirus.
• Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;382(10):970-971. doi:10.1056/NEJMc2001468
• Salvatore CM, Han J-Y, Acker KP, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Heal. July 2020. doi:10.1016/S2352-4642(20)30235-2
• Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):759-765. doi:10.15585/mmwr.mm6924e2
• Su S, Wong G, Shi W, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016;24(6):490-502. doi:10.1016/j.tim.2016.03.003
• The Lancet. COVID-19: a new lens for non-communicable diseases. Lancet. 2020;396(10252):649. doi:10.1016/S0140-6736(20)31856-0
• Tong Z-D, Tang A, Li K-F, et al. Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg Infect Dis. 2020;26(5):1052-1054. doi:10.3201/eid2605.200198
• Van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564-1567. doi:10.1056/NEJMc2004973
• Walker K, O’Donoghue K, Grace N, et al. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG An Int J Obstet Gynaecol. July 2020:1471-0528.16362. doi:10.1111/1471-0528.16362
• Wang X, Wang S, Sun L, Qin G. Prevalence of diabetes mellitus in 2019 novel coronavirus: A meta-analysis. Diabetes Res Clin Pract. 2020;164:108200. doi:10.1016/j.diabres.2020.108200
• World Health Organization. Advice on the use of masks in the context of COVID-19. 5 june.
• World Health Organization. Clinical Management of COVID-19: Interim Guidance, 27 May 2020. World Health Organization; 2020. https://apps.who.int/iris/handle/10665/332196.
• World Health Organization. Draft landscape of COVID-19 candidate vaccines.https://www.who.int/docs/default-source/coronaviruse/novel-coronavirus-landscape-covid-19-(3).pdf?sfvrsn=9c18d69c_7&download=true. Published August 28, 2020.
• World Health Organization. Global Report on Diabetes. Geneva, Switzerland: World Health Organization; 2016. https://www.who.int/diabetes/global-report/en/.
• World Health Organization. Infection Prevention and Control of Epidemic- and Pandemic-Prone Acute Respiratory Infections in Health Care. Geneva: World Health Organization; 2014. https://www.who.int/csr/bioriskreduction/infection_control/publication/en/.
• World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. 29-07-2020. https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations. Published 2020. Accessed August 17, 2020.
• World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. Accessed August 15, 2020.
• World Health Organization. Novel Coronavirus – China. 12 January. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Published 2020. Accessed August 15, 2020.
• World Health Organization. Pneumonia of unknown cause – China. 5 January. https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/. Published 2020. Accessed August 15, 2020.
• World Health Organization. Protect yourself and others from the spread COVID-19. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public. Published 2020. Accessed August 29, 2020.
• World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.
• Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA. 2020;323(13):1239. doi:10.1001/jama.2020.2648
• Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (80- ). 2020;367(6485):1444-1448. doi:10.1126/science.abb2762
• Zhang P, Li J, Liu H, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020;8(1):8. doi:10.1038/s41413-020-0084-5
• Zheng J. SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat. Int J Biol Sci. 2020;16(10):1678-1685. doi:10.7150/ijbs.45053
• Zhou Y, Yang Q, Chi J, et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. Int J Infect Dis. 2020;99:47-56. doi:10.1016/j.ijid.2020.07.029
• Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14(2):185-192. doi:10.1007/s11684-020-0754-0